United States Biotechnology & Medical Research

Oramed Pharmaceuticals Inc (ORMP)

Track

Track

Oramed Pharmaceuticals experienced significant insider trading activity recently, with executives initiating sales totaling over $2 million. These transactions occurred following the company's latest results financiers, which showed an earnings miss. Despite a 15.2% stock price increase over the past quarter, leadership has moved to divest portions of their holdings through planned and proposed market orders.
Ticker: ORMP Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Oramed Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Gabay Avraham Chief Financial Officer Officer
Transaction date
Planned sale
Price
236.44
Quantity 46,541 -20.5%
Value US$268,443
Hexter Joshua COO & CBO Officer
Transaction date
Planned sale
Price
55.30
Quantity 2,600 +30.2%
Value US$368,968
Hexter Joshua Officer Officer
Transaction date
Proposed sale
Price
172.07
Quantity 31,488
Value US$4,178,165
Gabay Avraham Officer Officer
Transaction date
Proposed sale
Price
4.81
Quantity 93,360
Value US$449,062
4.0
Mayer Arie Non-Executive Director
Transaction date
Purchase
Price
2.21
Quantity 3,800 +16.5%
Value US$8,398
4.0
Mayer Arie Non-Executive Director
Transaction date
Purchase
Price
2.22
Quantity 5,009 +27.8%
Value US$11,120
3.6
KIDRON NADAV President and CEO Executive Director
Transaction date
Purchase
Price
2.04
Quantity 26,000 +26.0%
Value US$53,014
0.5
Kidron Miriam Chief Scientific Officer Executive Director
Transaction date
Sale
Price
2.01
Quantity 100,000 -33.1%
Value US$201,000
3.6
KIDRON NADAV President and CEO Executive Director
Transaction date
Purchase
Price
2.01
Quantity 100,000 +inf%
Value US$201,000
4.1
Rozov Yadin Non-Executive Director
Transaction date
Purchase
Price
2.05
Quantity 50,000 +137.0%
Value US$102,450
4.1
Rozov Yadin Non-Executive Director
Transaction date
Purchase
Price
1.96
Quantity 20,000 +121.2%
Value US$39,120
Rabinowitz Michael Chief Commercial Officer Officer
Transaction date
Planned sale
Price
12.49
Quantity 11,900 -8.6%
Value US$148,651
Rabinowitz Michael Chief Commercial Officer Officer
Transaction date
Planned sale
Price
13.01
Quantity 1,425 -1.0%
Value US$18,544
3.5
RAKIN KEVIN Non-Executive Director
Transaction date
Sale
Price
9.41
Quantity 10,000 -17.6%
Value US$94,096
4.0
Mayer Arie Non-Executive Director
Transaction date
Sale
Price
25.60
Quantity 3,000 -100.0%
Value US$76,800
3.6
KIDRON NADAV President and CEO Executive Director Large shareholder
Transaction date
Planned sale
Price
20.11
Quantity 220,000 -25.3%
Value US$4,423,144
2.2
Sank Leonard
Transaction date
Purchase
Price
2.95
Quantity 10,000 +2.7%
Value US$29,500
2.2
Sank Leonard
Transaction date
Purchase
Price
2.90
Quantity 15,000 +4.3%
Value US$43,500
2.2
Sank Leonard
Transaction date
Purchase
Price
3.86
Quantity 4,497 +1.3%
Value US$17,336
2.2
Sank Leonard
Transaction date
Purchase
Price
3.74
Quantity 10,020 +3.0%
Value US$37,497
2.2
Sank Leonard
Transaction date
Purchase
Price
3.58
Quantity 20,000 +6.3%
Value US$71,562
2.2
Sank Leonard
Transaction date
Purchase
Price
3.47
Quantity 20,000 +6.8%
Value US$69,316
2.2
Sank Leonard
Transaction date
Purchase
Price
3.22
Quantity 1,320 +0.4%
Value US$4,250
Friedman Aviad Non-Executive Director
Transaction date
Purchase
Price
4.98
Quantity 2,000 +19.6%
Value US$9,960
Friedman Aviad Non-Executive Director
Transaction date
Purchase
Price
4.82
Quantity 500 +5.2%
Value US$2,410
KIDRON NADAV President and CEO Executive Director Large shareholder
Transaction date
Purchase
Price
5.92
Quantity 122 +0.0%
Value US$722
KIDRON NADAV President and CEO Executive Director Large shareholder
Transaction date
Sale
Price
5.98
Quantity 61 -0.0%
Value US$365
Kidron Miriam Chief Scientific Officer Executive Director
Transaction date
Sale
Price
8.50
Quantity 89,636 -54.4%
Value US$761,906
Li Xiaopeng
Transaction date
Purchase
Price
8.50
Quantity 89,636 +76.8%
Value US$761,906
Li Xiaopeng
Transaction date
Purchase
Price
6.33
Quantity 52,814 +82.7%
Value US$334,313
Kidron Miriam Chief Scientific Officer Executive Director
Transaction date
Sale
Price
6.33
Quantity 52,814 -37.1%
Value US$334,313
KIDRON NADAV President and CEO Executive Director Large shareholder
Transaction date
Purchase
Price
7.10
Quantity 100 +0.0%
Value US$710
KIDRON NADAV President and CEO Executive Director Large shareholder
Transaction date
Purchase
Price
7.00
Quantity 300 +0.0%
Value US$2,100
KIDRON NADAV President and CEO Executive Director Large shareholder
Transaction date
Purchase
Price
6.91
Quantity 300 +0.0%
Value US$2,073
KIDRON NADAV President and CEO Executive Director Large shareholder
Transaction date
Purchase
Price
6.90
Quantity 300 +0.0%
Value US$2,070
JACOB HAROLD Non-Executive Director
Transaction date
Sale
Price
6.45
Quantity 8,500 -34.1%
Value US$54,842
Kidron Miriam Chief Technology Officer Executive Director
Transaction date
Sale
Price
8.61
Quantity 24,000 -14.4%
Value US$206,707
Kidron Miriam Chief Technology Officer Executive Director
Transaction date
Sale
Price
9.08
Quantity 15,000 -8.3%
Value US$136,178
Kidron Miriam Chief Technology Officer Executive Director
Transaction date
Sale
Price
9.27
Quantity 11,000 -5.7%
Value US$101,915
Berelowitz Michael Non-Executive Director
Transaction date
Sale
Price
9.44
Quantity 700 -3.0%
Value US$6,608
Berelowitz Michael Non-Executive Director
Transaction date
Sale
Price
8.70
Quantity 761 -3.1%
Value US$6,621
Berelowitz Michael Non-Executive Director
Transaction date
Sale
Price
8.70
Quantity 539 -2.2%
Value US$4,689
KIDRON NADAV President and CEO Executive Director Large shareholder
Transaction date
Purchase
Price
6.64
Quantity 100 +0.0%
Value US$664
KIDRON NADAV President and CEO Executive Director Large shareholder
Transaction date
Purchase
Price
6.63
Quantity 200 +0.0%
Value US$1,326
KIDRON NADAV President and CEO Executive Director Large shareholder
Transaction date
Purchase
Price
6.62
Quantity 100 +0.0%
Value US$662
KIDRON NADAV President and CEO Executive Director Large shareholder
Transaction date
Purchase
Price
6.55
Quantity 200 +0.0%
Value US$1,310
KIDRON NADAV President and CEO Executive Director Large shareholder
Transaction date
Purchase
Price
4.00
Quantity 100 +0.0%
Value US$400
KIDRON NADAV President and CEO Executive Director Large shareholder
Transaction date
Purchase
Price
3.92
Quantity 1,100 +0.1%
Value US$4,312
KIDRON NADAV President and CEO Executive Director Large shareholder
Transaction date
Purchase
Price
3.95
Quantity 400 +0.0%
Value US$1,580
KIDRON NADAV President and CEO Executive Director Large shareholder
Transaction date
Purchase
Price
3.80
Quantity 500 +0.1%
Value US$1,900
KIDRON NADAV President and CEO Executive Director Large shareholder
Transaction date
Purchase
Price
3.78
Quantity 500 +0.1%
Value US$1,890
Kidron Miriam Chief Technology Officer Executive Director
Transaction date
Sale
Price
8.44
Quantity 8,699 -7.8%
Value US$73,401
Kidron Miriam Chief Technology Officer Executive Director
Transaction date
Sale
Price
8.40
Quantity 23,000 -17.1%
Value US$193,260
Kidron Miriam Chief Technology Officer Executive Director
Transaction date
Sale
Price
9.41
Quantity 8,301 -5.8%
Value US$78,112
REGALS CAPITAL MANAGEMENT LP Large shareholder
Transaction date
Purchase
Price
4.44
Quantity 2,252 +0.2%
Value US$9,999
JACOB HAROLD Non-Executive Director
Transaction date
Purchase
Price
14.41
Quantity 700 +inf%
Value US$10,087
Kidron Miriam Chief Technology Officer Executive Director
Transaction date
Sale
Price
12.03
Quantity 137,300 -100.0%
Value US$1,651,582
Berelowitz Michael Non-Executive Director
Transaction date
Sale
Price
10.50
Quantity 9,434 -100.0%
Value US$99,057
REGALS CAPITAL MANAGEMENT LP Large shareholder
Transaction date
Purchase
Price
10.90
Quantity 47,300 +3.4%
Value US$515,551
REGALS CAPITAL MANAGEMENT LP Large shareholder
Transaction date
Purchase
Price
10.15
Quantity 27,700 +2.0%
Value US$281,257
REGALS CAPITAL MANAGEMENT LP Large shareholder
Transaction date
Purchase
Price
14.96
Quantity 26,800 +2.0%
Value US$400,941
REGALS CAPITAL MANAGEMENT LP Large shareholder
Transaction date
Purchase
Price
16.32
Quantity 24,492 +1.8%
Value US$399,798
JACOB HAROLD Non-Executive Director
Transaction date
Sale
Price
15.00
Quantity 834 -100.0%
Value US$12,510
REGALS CAPITAL MANAGEMENT LP Large shareholder
Transaction date
Purchase
Price
7.40
Quantity 6,630 +0.5%
Value US$49,034
Sank Leonard Non-Executive Director
Transaction date
Purchase
Price
0.32
Quantity 937,500 +inf%
Value US$300,000
Bronfeld Zeev Large shareholder
Transaction date
Sale
Price
0.28
Quantity 350,000 -5.7%
Value US$98,000
Bronfeld Zeev Large shareholder
Transaction date
Purchase
Price
0.32
Quantity 781,250 +12.1%
Value US$250,000
Sank Leonard Non-Executive Director
Transaction date
Purchase
Price
0.25
Quantity 5,000 +0.1%
Value US$1,250
Sank Leonard Non-Executive Director
Transaction date
Purchase
Price
0.25
Quantity 15,650 +0.4%
Value US$3,912
Sank Leonard Non-Executive Director
Transaction date
Purchase
Price
0.30
Quantity 22,840 +0.6%
Value US$6,852
Sank Leonard Non-Executive Director
Transaction date
Purchase
Price
0.30
Quantity 48,000 +1.4%
Value US$14,400
Sank Leonard Non-Executive Director
Transaction date
Purchase
Price
0.30
Quantity 121,160 +3.6%
Value US$35,948
Sank Leonard Non-Executive Director
Transaction date
Purchase
Price
0.24
Quantity 85,000 +2.6%
Value US$20,247
Sank Leonard Non-Executive Director
Transaction date
Purchase
Price
0.25
Quantity 10,000 +0.3%
Value US$2,500
Young Michael Fmr.Pres,CEO,Director,10%Owner
Transaction date
Sale
Price
0.00
Quantity 6,000,000 -100.0%
Value US$19,800
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-02 2026-07-01 PlS Planned sale
Gabay Avraham

Chief Financial Officer

Officer
46,541 -20.5%
236.44
US$268,443 		46,541 -20.5% 236.44 US$268,443
2026-07-02 2026-07-01 PlS Planned sale
Hexter Joshua

COO & CBO

Officer
2,600 +30.2%
55.30
US$368,968 		2,600 +30.2% 55.30 US$368,968
2026-07-01 2026-07-01 PrS Proposed sale
Hexter Joshua

Officer

Officer
31,488
172.07
US$4,178,165 		31,488 172.07 US$4,178,165
2026-07-01 2026-07-01 PrS Proposed sale
Gabay Avraham

Officer

Officer
93,360
4.81
US$449,062 		93,360 4.81 US$449,062
2023-04-04 2023-04-04 B Purchase
4.0
Mayer Arie
Non-Executive Director
3,800 +16.5%
2.21
US$8,398 		3,800 +16.5% 2.21 US$8,398
2023-04-04 2023-04-03 B Purchase
4.0
Mayer Arie
Non-Executive Director
5,009 +27.8%
2.22
US$11,120 		5,009 +27.8% 2.22 US$11,120
2023-03-16 2023-03-16 B Purchase
3.6
KIDRON NADAV

President and CEO

Executive Director
26,000 +26.0%
2.04
US$53,014 		26,000 +26.0% 2.04 US$53,014
2023-03-15 2023-03-14 S Sale
0.5
Kidron Miriam

Chief Scientific Officer

Executive Director
100,000 -33.1%
2.01
US$201,000 		100,000 -33.1% 2.01 US$201,000
2023-03-15 2023-03-14 B Purchase
3.6
KIDRON NADAV

President and CEO

Executive Director
100,000 +inf%
2.01
US$201,000 		100,000 +inf% 2.01 US$201,000
2023-03-15 2023-03-14 B Purchase
4.1
Rozov Yadin
Non-Executive Director
50,000 +137.0%
2.05
US$102,450 		50,000 +137.0% 2.05 US$102,450
2023-03-15 2023-03-13 B Purchase
4.1
Rozov Yadin
Non-Executive Director
20,000 +121.2%
1.96
US$39,120 		20,000 +121.2% 1.96 US$39,120
2023-01-04 2023-01-03 PlS Planned sale
Rabinowitz Michael

Chief Commercial Officer

Officer
11,900 -8.6%
12.49
US$148,651 		11,900 -8.6% 12.49 US$148,651
2023-01-04 2023-01-03 PlS Planned sale
Rabinowitz Michael

Chief Commercial Officer

Officer
1,425 -1.0%
13.01
US$18,544 		1,425 -1.0% 13.01 US$18,544
2022-03-22 2022-03-21 S Sale
3.5
RAKIN KEVIN
Non-Executive Director
10,000 -17.6%
9.41
US$94,096 		10,000 -17.6% 9.41 US$94,096
2022-05-10 2021-11-01 S Sale
4.0
Mayer Arie
Non-Executive Director
3,000 -100.0%
25.60
US$76,800 		3,000 -100.0% 25.60 US$76,800
2021-08-11 2021-08-09 PlS Planned sale
3.6
KIDRON NADAV

President and CEO

Executive Director Large shareholder
220,000 -25.3%
20.11
US$4,423,144 		220,000 -25.3% 20.11 US$4,423,144
2019-09-11 2019-09-09 B Purchase
2.2
Sank Leonard
10,000 +2.7%
2.95
US$29,500 		10,000 +2.7% 2.95 US$29,500
2019-09-11 2019-09-09 B Purchase
2.2
Sank Leonard
15,000 +4.3%
2.90
US$43,500 		15,000 +4.3% 2.90 US$43,500
2019-07-18 2019-07-18 B Purchase
2.2
Sank Leonard
4,497 +1.3%
3.86
US$17,336 		4,497 +1.3% 3.86 US$17,336
2019-07-18 2019-07-17 B Purchase
2.2
Sank Leonard
10,020 +3.0%
3.74
US$37,497 		10,020 +3.0% 3.74 US$37,497
2019-07-18 2019-07-17 B Purchase
2.2
Sank Leonard
20,000 +6.3%
3.58
US$71,562 		20,000 +6.3% 3.58 US$71,562
2019-07-18 2019-07-16 B Purchase
2.2
Sank Leonard
20,000 +6.8%
3.47
US$69,316 		20,000 +6.8% 3.47 US$69,316
2019-07-15 2019-07-11 B Purchase
2.2
Sank Leonard
1,320 +0.4%
3.22
US$4,250 		1,320 +0.4% 3.22 US$4,250
2018-08-13 2018-08-09 B Purchase Friedman Aviad Non-Executive Director
2,000 +19.6%
4.98
US$9,960 		2,000 +19.6% 4.98 US$9,960
2018-08-13 2018-08-09 B Purchase Friedman Aviad Non-Executive Director
500 +5.2%
4.82
US$2,410 		500 +5.2% 4.82 US$2,410
2018-07-12 2018-07-11 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
122 +0.0%
5.92
US$722 		122 +0.0% 5.92 US$722
2018-07-12 2018-07-10 S Sale KIDRON NADAV

President and CEO

Executive Director Large shareholder
61 -0.0%
5.98
US$365 		61 -0.0% 5.98 US$365
2017-08-03 2017-08-02 S Sale Kidron Miriam

Chief Scientific Officer

Executive Director
89,636 -54.4%
8.50
US$761,906 		89,636 -54.4% 8.50 US$761,906
2017-08-03 2017-08-02 B Purchase Li Xiaopeng
89,636 +76.8%
8.50
US$761,906 		89,636 +76.8% 8.50 US$761,906
2017-04-19 2017-04-19 B Purchase Li Xiaopeng
52,814 +82.7%
6.33
US$334,313 		52,814 +82.7% 6.33 US$334,313
2017-04-19 2017-04-19 S Sale Kidron Miriam

Chief Scientific Officer

Executive Director
52,814 -37.1%
6.33
US$334,313 		52,814 -37.1% 6.33 US$334,313
2016-05-12 2016-05-12 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
100 +0.0%
7.10
US$710 		100 +0.0% 7.10 US$710
2016-05-12 2016-05-12 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
300 +0.0%
7.00
US$2,100 		300 +0.0% 7.00 US$2,100
2016-05-12 2016-05-12 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
300 +0.0%
6.91
US$2,073 		300 +0.0% 6.91 US$2,073
2016-05-12 2016-05-12 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
300 +0.0%
6.90
US$2,070 		300 +0.0% 6.90 US$2,070
2016-03-14 2016-03-10 S Sale JACOB HAROLD Non-Executive Director
8,500 -34.1%
6.45
US$54,842 		8,500 -34.1% 6.45 US$54,842
2015-12-31 2015-12-30 S Sale Kidron Miriam

Chief Technology Officer

Executive Director
24,000 -14.4%
8.61
US$206,707 		24,000 -14.4% 8.61 US$206,707
2015-12-31 2015-12-29 S Sale Kidron Miriam

Chief Technology Officer

Executive Director
15,000 -8.3%
9.08
US$136,178 		15,000 -8.3% 9.08 US$136,178
2015-12-31 2015-12-28 S Sale Kidron Miriam

Chief Technology Officer

Executive Director
11,000 -5.7%
9.27
US$101,915 		11,000 -5.7% 9.27 US$101,915
2015-12-10 2015-12-09 S Sale Berelowitz Michael Non-Executive Director
700 -3.0%
9.44
US$6,608 		700 -3.0% 9.44 US$6,608
2015-12-09 2015-12-08 S Sale Berelowitz Michael Non-Executive Director
761 -3.1%
8.70
US$6,621 		761 -3.1% 8.70 US$6,621
2015-12-09 2015-12-07 S Sale Berelowitz Michael Non-Executive Director
539 -2.2%
8.70
US$4,689 		539 -2.2% 8.70 US$4,689
2015-05-12 2015-05-12 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
100 +0.0%
6.64
US$664 		100 +0.0% 6.64 US$664
2015-05-12 2015-05-12 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
200 +0.0%
6.63
US$1,326 		200 +0.0% 6.63 US$1,326
2015-05-12 2015-05-12 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
100 +0.0%
6.62
US$662 		100 +0.0% 6.62 US$662
2015-05-12 2015-05-12 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
200 +0.0%
6.55
US$1,310 		200 +0.0% 6.55 US$1,310
2015-03-20 2015-03-19 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
100 +0.0%
4.00
US$400 		100 +0.0% 4.00 US$400
2015-03-20 2015-03-19 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
1,100 +0.1%
3.92
US$4,312 		1,100 +0.1% 3.92 US$4,312
2015-03-20 2015-03-19 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
400 +0.0%
3.95
US$1,580 		400 +0.0% 3.95 US$1,580
2015-03-20 2015-03-18 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
500 +0.1%
3.80
US$1,900 		500 +0.1% 3.80 US$1,900
2015-03-20 2015-03-18 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
500 +0.1%
3.78
US$1,890 		500 +0.1% 3.78 US$1,890
2014-09-12 2014-09-11 S Sale Kidron Miriam

Chief Technology Officer

Executive Director
8,699 -7.8%
8.44
US$73,401 		8,699 -7.8% 8.44 US$73,401
2014-09-12 2014-09-10 S Sale Kidron Miriam

Chief Technology Officer

Executive Director
23,000 -17.1%
8.40
US$193,260 		23,000 -17.1% 8.40 US$193,260
2014-09-08 2014-09-04 S Sale Kidron Miriam

Chief Technology Officer

Executive Director
8,301 -5.8%
9.41
US$78,112 		8,301 -5.8% 9.41 US$78,112
2014-06-10 2014-06-06 B Purchase REGALS CAPITAL MANAGEMENT LP Large shareholder
2,252 +0.2%
4.44
US$9,999 		2,252 +0.2% 4.44 US$9,999
2014-04-18 2014-04-14 B Purchase JACOB HAROLD Non-Executive Director
700 +inf%
14.41
US$10,087 		700 +inf% 14.41 US$10,087
2014-04-03 2014-04-01 S Sale Kidron Miriam

Chief Technology Officer

Executive Director
137,300 -100.0%
12.03
US$1,651,582 		137,300 -100.0% 12.03 US$1,651,582
2014-04-02 2014-03-31 S Sale Berelowitz Michael Non-Executive Director
9,434 -100.0%
10.50
US$99,057 		9,434 -100.0% 10.50 US$99,057
2014-03-25 2014-03-25 B Purchase REGALS CAPITAL MANAGEMENT LP Large shareholder
47,300 +3.4%
10.90
US$515,551 		47,300 +3.4% 10.90 US$515,551
2014-03-25 2014-03-24 B Purchase REGALS CAPITAL MANAGEMENT LP Large shareholder
27,700 +2.0%
10.15
US$281,257 		27,700 +2.0% 10.15 US$281,257
2014-02-06 2014-02-06 B Purchase REGALS CAPITAL MANAGEMENT LP Large shareholder
26,800 +2.0%
14.96
US$400,941 		26,800 +2.0% 14.96 US$400,941
2014-02-06 2014-02-05 B Purchase REGALS CAPITAL MANAGEMENT LP Large shareholder
24,492 +1.8%
16.32
US$399,798 		24,492 +1.8% 16.32 US$399,798
2014-01-29 2013-12-30 S Sale JACOB HAROLD Non-Executive Director
834 -100.0%
15.00
US$12,510 		834 -100.0% 15.00 US$12,510
2013-07-12 2013-07-10 B Purchase REGALS CAPITAL MANAGEMENT LP Large shareholder
6,630 +0.5%
7.40
US$49,034 		6,630 +0.5% 7.40 US$49,034
2011-10-06 2011-10-04 B Purchase Sank Leonard Non-Executive Director
937,500 +inf%
0.32
US$300,000 		937,500 +inf% 0.32 US$300,000
2011-09-28 2011-09-27 S Sale Bronfeld Zeev Large shareholder
350,000 -5.7%
0.28
US$98,000 		350,000 -5.7% 0.28 US$98,000
2011-04-04 2011-03-31 B Purchase Bronfeld Zeev Large shareholder
781,250 +12.1%
0.32
US$250,000 		781,250 +12.1% 0.32 US$250,000
2008-01-17 2008-01-16 B Purchase Sank Leonard Non-Executive Director
5,000 +0.1%
0.25
US$1,250 		5,000 +0.1% 0.25 US$1,250
2008-01-17 2008-01-15 B Purchase Sank Leonard Non-Executive Director
15,650 +0.4%
0.25
US$3,912 		15,650 +0.4% 0.25 US$3,912
2008-01-09 2008-01-07 B Purchase Sank Leonard Non-Executive Director
22,840 +0.6%
0.30
US$6,852 		22,840 +0.6% 0.30 US$6,852
2008-01-07 2008-01-03 B Purchase Sank Leonard Non-Executive Director
48,000 +1.4%
0.30
US$14,400 		48,000 +1.4% 0.30 US$14,400
2008-01-03 2008-01-02 B Purchase Sank Leonard Non-Executive Director
121,160 +3.6%
0.30
US$35,948 		121,160 +3.6% 0.30 US$35,948
2008-01-03 2007-12-31 B Purchase Sank Leonard Non-Executive Director
85,000 +2.6%
0.24
US$20,247 		85,000 +2.6% 0.24 US$20,247
2008-01-03 2007-12-31 B Purchase Sank Leonard Non-Executive Director
10,000 +0.3%
0.25
US$2,500 		10,000 +0.3% 0.25 US$2,500
2004-06-10 2004-05-27 S Sale Young Michael

Fmr.Pres,CEO,Director,10%Owner
6,000,000 -100.0%
0.00
US$19,800 		6,000,000 -100.0% 0.00 US$19,800
Explore more

More insider trading research around Oramed Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America